Generate Biomedicines, Inc.
GENB
$15.64
$0.614.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -67.26M | -61.45M | -52.43M | ||
| Total Depreciation and Amortization | 3.22M | 3.27M | 3.32M | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 10.54M | 8.44M | 1.72M | ||
| Change in Net Operating Assets | -4.46M | -30.65M | -1.36M | ||
| Cash from Operations | -57.94M | -80.39M | -48.75M | ||
| Capital Expenditure | -933.00K | -3.78M | -154.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 34.24M | -256.15M | -16.91M | ||
| Cash from Investing | 33.31M | -259.93M | -17.07M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -993.00K | -1.12M | -2.42M | ||
| Issuance of Common Stock | 414.00K | 372.51M | 154.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -1.00K | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 0.00 | 7.50M | 2.00M | ||
| Cash from Financing | -579.00K | 378.89M | -263.00K | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -25.21M | 38.57M | -66.08M | ||